The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Merck & Co Inc’s stock clocked out at $80.79, up 1.16% from its previous closing price of $79.86. In other words, the price has increased by $1.16 from its previous closing price. On the day, 9.98 million shares were traded. MRK stock price reached its highest trading level at $81.125 during the session, while it also had its lowest trading level at $79.565.
Ratios:
To gain a deeper understanding of MRK’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 21.74 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.91. For the most recent quarter (mrq), Quick Ratio is recorded 1.16 and its Current Ratio is at 1.41. In the meantime, Its Debt-to-Equity ratio is 0.72 whereas as Long-Term Debt/Eq ratio is at 0.69.
On April 22, 2025, Cantor Fitzgerald started tracking the stock assigning a Neutral rating and target price of $85.
Deutsche Bank Downgraded its Buy to Hold on February 18, 2025, whereas the target price for the stock was revised from $128 to $105.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 25 ’25 when Smart Dalton E. III sold 4,262 shares for $82.76 per share. The transaction valued at 352,723 led to the insider holds 7,778 shares of the business.
DALTON SMART bought 4,262 shares of MRK for $352,723 on Apr 25 ’25. On Feb 19 ’25, another insider, Oosthuizen Johannes Jacobus, who serves as the President, U.S. Market of the company, sold 8,500 shares for $84.09 each. As a result, the insider received 714,745 and left with 30,705 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRK now has a Market Capitalization of 202866114560 and an Enterprise Value of 228547215360. As of this moment, Merck’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.46, and their Forward P/E ratio for the next fiscal year is 8.36. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.11. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.20 while its Price-to-Book (P/B) ratio in mrq is 4.21. Its current Enterprise Value per Revenue stands at 3.593 whereas that against EBITDA is 7.839.
Stock Price History:
The Beta on a monthly basis for MRK is 0.38, which has changed by -0.28180283 over the last 52 weeks, in comparison to a change of 0.21149921 over the same period for the S&P500. Over the past 52 weeks, MRK has reached a high of $120.30, while it has fallen to a 52-week low of $73.31. The 50-Day Moving Average of the stock is 0.49%, while the 200-Day Moving Average is calculated to be -10.04%.
Shares Statistics:
It appears that MRK traded 15.25M shares on average per day over the past three months and 13845810 shares per day over the past ten days. A total of 2.51B shares are outstanding, with a floating share count of 2.51B. Insiders hold about 0.06% of the company’s shares, while institutions hold 80.17% stake in the company. Shares short for MRK as of 1752537600 were 28773023 with a Short Ratio of 1.89, compared to 1749772800 on 35799415. Therefore, it implies a Short% of Shares Outstanding of 28773023 and a Short% of Float of 1.28.
Dividends & Splits
With its trailing 12-month dividend rate of 3.16, MRK has a forward annual dividend rate of 3.20. Against a Trailing Annual Dividend Yield of 0.039569248The stock’s 5-year Average Dividend Yield is 3.01. The current Payout Ratio is 46.32% for MRK, which recently paid a dividend on 2025-06-16 with an ex-dividend date of 2025-09-15. Stock splits for the company last occurred on 2021-06-03 when the company split stock in a 1048:1000 ratio.
